Clinical trial
The Effect of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) During in Vitro Culture of Human Embryos on Subsequent Implantation Rates.
NCT00565747 is registered in ClinicalTrials.gov with Origio A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) During in Vitro Culture of Human Embryos on Subsequent Implantation Rates.
- Lead sponsor
- Origio A/S
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2007
- Completion date
- September 30, 2011
- Enrollment
- 1,332 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.